Webinar: Anti-Corruption Compliance in Pharma and Medical Device Industries

February 26, 2019, 12 Noon EST

Sign up HERE

FCPA enforcement against drug and device companies continues at a robust rate. Given the high-risk nature of pharmaceutical and medical device industries and significant interactions with foreign government officials, drug and device companies face a number of challenges in designing and implementing effective anti-corruption compliance programs. 

Join Michael Volkov, CEO at The Volkov Law Group, as he discusses recent trends and compliance issues facing drug and device companies in the global marketplace.